CLINICAL_TRIALS
trial_result
· 2020-12-19
Clinical Trial Update: DPP4 Inhibitor on Glycemic Variability [Phase 4]
Summary
A Phase 4 clinical trial evaluating a DPP4 inhibitor's effect on glycemic variability in type 2 diabetes has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University Malaysia Sarawak | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED